Elizabeth D Ballard1, Laura Waldman2, Julia S Yarrington2, Nimesha Gerlus2, Laura E Newman2, Laura Lee3, Mary Sparks3, Victoria Liberty4, Maryland Pao5, Lawrence Park2, Carlos A Zarate2. 1. Section on the Neurobiology and Treatment of Mood Disorders, Intramural Research Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, United States of America. Electronic address: Elizabeth.Ballard@nih.gov. 2. Section on the Neurobiology and Treatment of Mood Disorders, Intramural Research Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, United States of America. 3. Office of Patient Safety and Clinical Quality, Clinical Center, National Institutes of Health, Bethesda, MD, United States of America. 4. Nursing Department, Clinical Center, National Institutes of Health, Bethesda, MD 20892, United States of America. 5. Office of the Clinical Director, Intramural Research Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, United States of America.
Abstract
OBJECTIVE: Suicide is a public health threat. Nevertheless, the research literature on actively suicidal participants is relatively sparse, in part because they are often excluded from medical, psychiatric, and psychological research for a host of logistical, ethical, and safety concerns. These obstacles to research participation and enrollment may contribute to our lack of understanding regarding the neurobiology of the suicidal crisis as well as to the dearth of evidence concerning both risk prediction and treatment. METHOD: In order to directly investigate neurobiological markers of acute suicide risk, the National Institute of Mental Health Intramural Research Program (NIMH-IRP) implemented the Neurobiology of Suicide protocol. In this protocol, actively suicidal individuals consent to research for both neurobiological assessment and potential rapid-acting interventions. RESULTS AND CONCLUSIONS: This article reviews lessons learned from implementing this protocol in the hopes of assisting future research on the neurobiology of suicide. Areas of specific discussion include the Failure Modes and Effects Analysis (FMEA), recruitment and informed consent, participant monitoring, and the safety of the physical environment. Published by Elsevier Inc.
OBJECTIVE: Suicide is a public health threat. Nevertheless, the research literature on actively suicidal participants is relatively sparse, in part because they are often excluded from medical, psychiatric, and psychological research for a host of logistical, ethical, and safety concerns. These obstacles to research participation and enrollment may contribute to our lack of understanding regarding the neurobiology of the suicidal crisis as well as to the dearth of evidence concerning both risk prediction and treatment. METHOD: In order to directly investigate neurobiological markers of acute suicide risk, the National Institute of Mental Health Intramural Research Program (NIMH-IRP) implemented the Neurobiology of Suicide protocol. In this protocol, actively suicidal individuals consent to research for both neurobiological assessment and potential rapid-acting interventions. RESULTS AND CONCLUSIONS: This article reviews lessons learned from implementing this protocol in the hopes of assisting future research on the neurobiology of suicide. Areas of specific discussion include the Failure Modes and Effects Analysis (FMEA), recruitment and informed consent, participant monitoring, and the safety of the physical environment. Published by Elsevier Inc.
Authors: Thomas E Joiner; Yeates Conwell; Kathleen Kara Fitzpatrick; Tracy K Witte; Norman B Schmidt; Marcelo T Berlim; Marcelo P A Fleck; M David Rudd Journal: J Abnorm Psychol Date: 2005-05
Authors: Madelyn S Gould; Frank A Marrocco; Marjorie Kleinman; John Graham Thomas; Katherine Mostkoff; Jean Cote; Mark Davies Journal: JAMA Date: 2005-04-06 Impact factor: 56.272
Authors: Kelly Posner; Gregory K Brown; Barbara Stanley; David A Brent; Kseniya V Yershova; Maria A Oquendo; Glenn W Currier; Glenn A Melvin; Laurence Greenhill; Sa Shen; J John Mann Journal: Am J Psychiatry Date: 2011-12 Impact factor: 18.112
Authors: Matthew K Nock; Irving Hwang; Nancy Sampson; Ronald C Kessler; Matthias Angermeyer; Annette Beautrais; Guilherme Borges; Evelyn Bromet; Ronny Bruffaerts; Giovanni de Girolamo; Ron de Graaf; Silvia Florescu; Oye Gureje; Josep Maria Haro; Chiyi Hu; Yueqin Huang; Elie G Karam; Norito Kawakami; Viviane Kovess; Daphna Levinson; Jose Posada-Villa; Rajesh Sagar; Toma Tomov; Maria Carmen Viana; David R Williams Journal: PLoS Med Date: 2009-08-11 Impact factor: 11.069
Authors: David A Jobes; Kathryn N Nelson; Erin M Peterson; Daniel Pentiuc; Vanessa Downing; Kristen Francini; Amy Kiernan Journal: Suicide Life Threat Behav Date: 2004
Authors: Samuel T Wilkinson; Elizabeth D Ballard; Michael H Bloch; Sanjay J Mathew; James W Murrough; Adriana Feder; Peter Sos; Gang Wang; Carlos A Zarate; Gerard Sanacora Journal: Am J Psychiatry Date: 2017-10-03 Impact factor: 18.112
Authors: Deborah M Stone; Thomas R Simon; Katherine A Fowler; Scott R Kegler; Keming Yuan; Kristin M Holland; Asha Z Ivey-Stephenson; Alex E Crosby Journal: MMWR Morb Mortal Wkly Rep Date: 2018-06-08 Impact factor: 17.586
Authors: Elizabeth D Ballard; Jessica R Gilbert; Jessica S Fields; Allison C Nugent; Carlos A Zarate Journal: Front Psychiatry Date: 2020-09-24 Impact factor: 4.157